Print Page     Close Window     
20-F
MESOBLAST LTD filed this Form 20-F on 08/31/2018
Entire Document
 

Mesoblast Limited

Consolidated Statement of Changes in Equity

 

(in U.S. dollars, in thousands)

 

Note

 

Issued Capital

 

 

Share Option

Reserve

 

 

Investment

Revaluation

Reserve

 

 

Foreign

Currency

Translation Reserve

 

 

Retained

Earnings

 

 

Total

 

Balance as of July 1, 2015

 

 

 

 

709,191

 

 

 

60,740

 

 

 

 

 

 

(37,984

)

 

 

(263,960

)

 

 

467,987

 

Loss for the period

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(4,127

)

 

 

(4,127

)

Other comprehensive loss

 

 

 

 

 

 

 

 

 

 

(334

)

 

 

(705

)

 

 

 

 

 

(1,039

)

Total comprehensive loss for the period

 

 

 

 

 

 

 

 

 

 

(334

)

 

 

(705

)

 

 

(4,127

)

 

 

(5,166

)

Transactions with owners in their

   capacity as owners:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contributions of equity net of transaction costs

 

 

 

 

60,947

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

60,947

 

 

 

7(a)

 

 

60,947

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

60,947

 

Transfer exercised options

 

 

 

 

134

 

 

 

(134

)

 

 

 

 

 

 

 

 

 

 

 

 

Fair value of share-based payments

 

17

 

 

 

 

 

3,149

 

 

 

 

 

 

 

 

 

 

 

 

3,149

 

Reclassification of modified options to liability

 

 

 

 

 

 

 

1,244

 

 

 

 

 

 

 

 

 

 

 

 

1,244

 

 

 

 

 

 

134

 

 

 

4,259

 

 

 

 

 

 

 

 

 

 

 

 

4,393

 

Balance as of June 30, 2016

 

 

 

 

770,272

 

 

 

64,999

 

 

 

(334

)

 

 

(38,689

)

 

 

(268,087

)

 

 

528,161

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of 1 July 2016

 

 

 

 

770,272

 

 

 

64,999

 

 

 

(334

)

 

 

(38,689

)

 

 

(268,087

)

 

 

528,161

 

Loss for the period

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(76,815

)

 

 

(76,815

)

Other comprehensive income

 

 

 

 

 

 

 

 

 

 

31

 

 

 

316

 

 

 

 

 

 

347

 

Total comprehensive profit/(loss) for the period

 

 

 

 

 

 

 

 

 

 

31

 

 

 

316

 

 

 

(76,815

)

 

 

(76,468

)

Transactions with owners in their

   capacity as owners:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contributions of equity net of transaction costs

 

 

 

 

60,140

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

60,140

 

 

 

7(a)

 

 

60,140

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

60,140

 

Transfer exercised options

 

 

 

 

13

 

 

 

(13

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Fair value of share-based payments

 

17

 

 

 

 

 

5,036

 

 

 

 

 

 

 

 

 

 

 

 

 

5,036

 

Reclassification of modified options from liability

 

 

 

 

 

 

 

(103

)

 

 

 

 

 

 

 

 

 

 

 

 

(103

)

 

 

 

 

 

13

 

 

 

4,920

 

 

 

 

 

 

 

 

 

 

 

 

4,933

 

Balance as of 30 June 2017

 

 

 

 

830,425

 

 

 

69,919

 

 

 

(303

)

 

 

(38,373

)

 

 

(344,902

)

 

 

516,766

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance as of July 1, 2017

 

 

 

 

830,425

 

 

 

69,919

 

 

 

(303

)

 

 

(38,373

)

 

 

(344,902

)

 

 

516,766

 

Loss for the period

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(35,290

)

 

 

(35,290

)

Other comprehensive income/(loss)

 

 

 

 

 

 

 

 

 

 

324

 

 

 

(903

)

 

 

 

 

 

(579

)

Total comprehensive profit/(loss) for the period

 

 

 

 

 

 

 

 

 

 

324

 

 

 

(903

)

 

 

(35,290

)

 

 

(35,869

)

Transactions with owners in their

   capacity as owners:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contributions of equity net of transaction costs

 

 

 

 

49,358

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

49,358

 

Contributions of equity for unissued ordinary

   shares, net of transaction costs

 

 

 

 

9,660

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

9,660

 

 

 

7(a)

 

 

59,018

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

59,018

 

Transfer of exercised options

 

 

 

 

38

 

 

 

(38

)

 

 

 

 

 

 

 

 

 

 

 

 

Fair value of share-based payments

 

17

 

 

 

 

 

5,959

 

 

 

 

 

 

 

 

 

 

 

 

5,959

 

Reclassification of modified options to liability

 

 

 

 

 

 

 

134

 

 

 

 

 

 

 

 

 

 

 

 

134

 

 

 

 

 

 

38

 

 

 

6,055

 

 

 

 

 

 

 

 

 

 

 

 

6,093

 

Balance as of June 30, 2018

 

 

 

 

889,481

 

 

 

75,974

 

 

 

21

 

 

 

(39,276

)

 

 

(380,192

)

 

 

546,008

 

 

The above consolidated statement of changes in equity should be read in conjunction with the accompanying Notes.

 

152

 



Copyright © 2015 Mesoblast Inc.